§ BIOTECHNOLOGY
USD · BiotechnologyDYN
DYNE THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.13
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
146 increased/new, 76 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 3.26 | EPS (TTM) | -3.22 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.6M | n/a | −2% |
| BlackRock, Inc. | 11.7M | 0.0% | +5% |
| Atlas Venture Life Science Advisors, LLC | 9.1M | 21.0% | ±0% |
| Fidelity Management | 8.9M | 0.0% | +36% |
| Orbis Allan Gray Ltd | 6.8M | 0.5% | +41% |
| State Street | 6.7M | 0.0% | −1% |
◇ AC INTELLIGENCE
Top institutional owners for DYN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER92.3% · 0 holders
OTHER4.8% · 158 holders
QUALITY / COMPOUNDER1.6% · 18 holders
PASSIVE / INDEX0.6% · 8 holders
DEALER / BANK0.6% · 21 holders
SYSTEMATIC / QUANT0.1% · 7 holders
INCOME / DEFENSIVE0.0% · 12 holders
TACTICAL / MACRO0.0% · 3 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for DYN in the last 180 days.